AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04682158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Subject will be treated with 30 mg po BID Propranolol for up to 6 weeks
Study NCT04682158 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT04682158 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT04682158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Given IV
Study NCT06198179 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: upper limb children action-observation training (UPCAT)
Description: upper limb children action-observation training (UPCAT) without visual Feedback
Study NCT06198179 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: upper limb children action-observation training (UP-CAT) with visual feedback
Description: upper limb children action-observation training (UP-CAT) with visual feedback: Mirror therapy as visual feedback
Study NCT06044142 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser
Description: Low level laser therapy
Study NCT06044142 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Laser
Description: Low level laser therapy
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT06129851 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Brachytherapy
Description: Undergo brachytherapy
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dual X-ray Absorptiometry
Description: Undergo DEXA scan
Study NCT06129851 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo external beam radiation therapy
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06129851 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PSMA PET Scan
Description: Undergo PSMA PET
Study NCT06129851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06129851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix
Description: Given PO
Study NCT05138458 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MT-101
Description: CD5 ATAK cells
Study NCT05138458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MT-101 + Conditioning (Lymphodepleting) Chemotherapy
Description: IV administration of fludarabine and cyclophosphamide
Study NCT06457659 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Rehab Group
Description: The first group of 25 Patients was fitted with Prosthesis with in 6months of duration after amputation. The basic theme was to check the physical psychological and QOL in early prostheic-fitted patients through WHO_QOL.
Study NCT06457659 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Delayed Rehab Group
Description: The 2nd group of 25 patients was fitted with Prosthesis after 6 months after amputation. No physical rehab was done during this period including physiotherapy and prosthetic treatment. The main aim was to check the significant impact of delayed rehabilitation.
Study NCT04359394 — intervention group
Intervention type: OTHER
Intervention: biological sampling
Description: In order to investigate the level of molecular pathophysiology, blood and punch biopsies will be collected of each patient. In up to two relatives per patient, 30mL blood will be collected only once.
Study NCT06608485 — intervention group
Intervention type: DEVICE
Intervention: HARMONIC 700 Shears
Description: There is no intervention, beyond necessary clinical care, in this study. HARMONIC 700 Shears for vessel transection were used according to instructions for use.
Study NCT04359394 — intervention group
Intervention type: OTHER
Intervention: Phenotypic description
Description: Phenotypic characterization of the patient's clinical features
Study NCT06593275 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Protection of the palatal donor area with flowable resin
Description: Use of fluid resin for protection of the palatal donor area to assess postoperative pain generated during14 days
Study NCT06593275 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Protection of the palatal donor area with a self-adhesive dressing
Description: Use of a self-adhesive dressing for protection of the palatal donor area to evaluate postoperative pain generated for 14 days
Study NCT06614582 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self-Supporting Nasopharyngeal Airway (ssNPA)
Description: The ssNPA device is a flexible, medical-grade silicone, nasal tube that is self-inserted into the airway through one nostril and worn during the night. It can also be used during the day. The device works by supporting collapsed airway muscles and keeping the airway open.~In addition to wearing the device, study team members will call monthly and collect certain data, and medical information and participants will be asked to have a sleep study at the 12-month visit.
Study NCT04856384 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: synchronisation abilities
Description: The study contains 1 descriptive and 3 experimental sessions. In the descriptive session, participant's clinical motor and cognitive functions are collected. In the first experimental session, participant's beat perception and synchronisation abilities is examined within a finger tapping paradigm. In the following experimental sessions participants synchronsiation abilities is examined during walking paradigms, to music and metronomes, with period and phase auditory manipulations
Study NCT04359394 — intervention group
Intervention type: OTHER
Intervention: Photography
Description: All affected areas will be photographed at each visit with 2-dimensional standardized photography
Study NCT05129774 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical surgery with PALND
Description: sufficient resection margins of the tumor, D3 dissection of the regional lymph nodes and para-aortic lymph node dissection from the bifurcation of iliac artery to the left renal vein via laparoscopic approach
Study NCT05129774 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radical surgery without PALND
Description: surgery includes sufficient resection margins of the tumor and D3 dissection of the regional lymph nodes without PALND
Study NCT04583735 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: TEPEZZA
Description: Intravenous infusion
Study NCT04583735 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion
Study NCT05775718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Recombinant
Description: Injection
Study NCT06702774 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Active case finding
Description: Villagers will be informed through public announcements and social workers. Before the campaign, social workers and village doctors will recruit participants and obtain consent through door-to-door visits. A mobile van equipped with an AI-assisted digital radiography (DR) machine and a refrigerator will visit villages on agreed dates. Participants will complete a TB symptom questionnaire and undergo DR screening. Those with TB symptoms or abnormal DR results will provide on-site sputum samples and collect additional morning and night samples. Trained staff will ensure proper collection and offer nebulizer support if needed. Samples will be transported daily to hospitals for testing using smear, culture, and GeneXpert. Participants with negative bacteriological results but abnormal findings will be referred for further clinical assessment.
Study NCT06721728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral health educational program
Description: Flyer distributed on the children with data about oral hygiene measures as well as diet advice related to their condition, in addition to modeling the correct tooth brushing habits using a cast and tooth brush.
Study NCT06721130 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FDG radiotracer
Description: Pilot study evaluating the role of FDG PET/CT in Cavernous sinus syndrome
Study NCT06001593 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: YPS-201b
Description: electrical stimulation device.
Study NCT05523050 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: active surgical intervention
Description: two kinds: one is colostomy, and the other one is colonic exclusion
Study NCT05001204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-NOTA-RM26
Description: 68Ga-NOTA-RM26 were injected into the patients before the PET/CT scans
Study NCT06001593 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: betahistine
Description: Relieve symptoms of balance disorders or dizziness
Study NCT06001593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: betahistine
Description: Relieve symptoms of balance disorders or dizziness
Study NCT06001593 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: betahistine
Description: Relieve symptoms of balance disorders or dizziness
Study NCT06001593 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: YPS-201b
Description: sham electrical stimulation device.
Study NCT05031559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking
Description: Participants are invited to imagine themselves in a positive situation after COVID-19 public health restrictions and guidelines are lifted. They are then reminded that their actions are able to change how soon this future can be achieved.
Study NCT05031559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Compassion Training
Description: Participants are invited to imagine themselves in someone else's situation, who is in a bad situation due to COVID-19 (e.g., ER nurse, family of someone in ICU). They are then reminded that their decisions have an impact on the occurrence of these situations.
Study NCT05031559 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Participants are invited to reflect on some COVID-19 related news, and reminded that their actions have bearing on the COVID-19 situation.
Study NCT05835154 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assessment
Description: Complete checklist
Study NCT05835154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT05835154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Undergo semi-structured feedback interview
Study NCT05835154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Review of medical records
Study NCT06415188 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video game with headset
Description: Half an hour before the first treatment in the morning, the screens around the patients' beds were closed by the researcher. The child was asked to choose one of the introduced games and the game he/she chose from the tablet was turned on. Children were asked to wear headphones for sound isolation and the sound was adjusted at the appropriate decibel setting. Half an hour before the treatment, children were allowed to play the video game until the treatment without any different warning. Physiologic Parameter Assessment Form, Child Anxiety and Fear Scale, Child Pain Scale were filled by the researcher 1 minute before and 1 minute after the procedure. Finally, Parental Satisfaction Scale was completed at the end of the intervention.
Study NCT04575909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aprosodia Intervention
Description: Intervention will focus on improving participants' use and understanding of emotional prosody using implicit and explicit cues, biofeedback, modeling, and feedback.
Study NCT04575909 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No-Intervention
Description: Sessions will comprise conversation about current events, recovery progress (including speech therapy goals targeted in outside intervention \[if relevant\]), hobbies, and other similar topics.
Study NCT05877508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AER002
Description: Intravenous infusion of AER002
Study NCT05877508 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo infusion
Study NCT04517604 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magventure MagProx100 with MagOption
Description: iTBS will be delivered utilizing the MagVentrure MagPro X100 with MagOption stimulator that includes active and placebo coils (C-B60 Butterfly coils). Only the active setting will be used.A MagVenture C-B60 coil will be used to deliver single pulse TMS to the non-dominant MC to identify the ab-ductor pollicis brevis (APB) muscle coordinates. The integrated Localite neuronavigation system will be used.
Study NCT05966896 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: implanted epidural stimulator
Description: implantable multi-programmable neurostimulation system to deliver electrical stimulation to neural targets in the spinal cord
Study NCT05908903 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Drinks with active ingredients such as poria and GABA
Description: Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.
Study NCT05908903 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Drinks with active ingredients such as poria and GABA
Description: Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.
Study NCT06359574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Competency Model for Corrections (CCM-C) Self-Directed Violence Prevention Training
Description: The Core Competency Model (CCM; Cramer et al., 2013, 2019) is an evidence-based educational training program for BHCs in suicide prevention core suicide prevention skills. The ten core competencies are: (1) Manage personal attitudes and reactions to suicide; (2) Maintain a collaborative stance toward the client; (3) Elicit evidence-based risk and protective factors; (4) Focus on current suicide plan and intent of suicidal ideation; (5) Determine risk level; (6) Enact a collaborative evidence-based treatment plan; (7) Notify and involve other persons; (8) Document risk, plan, and reasoning for clinical decisions; (9) Know the law concerning suicide, and; (10) Engage in debriefing and self-care. The CCM will be adapted for this pilot trial. In light of the SDV problem in carceral settings, the CCM for Corrections (CCM-C; Cramer, Kaniuka, \& Peiper, 2022) was adapted to address both suicide and self-injury assessment, treatment, and prevention.
Study NCT06140173 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low osmolar contrast
Description: 100 mL of 350 mg omnipaque will be administered via nasogastric tube
Study NCT06140173 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sterile water
Description: 100 mL of sterile water will be administered via nasogastric tube
Study NCT06362317 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toripalimab
Description: Toripalimab 240mg, intravenous infusion every 3 weeks until disease progression or occurrence of intolerable toxicity.
Study NCT06362317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Toripalimab 240mg, intravenous infusion every 3 weeks until disease progression or occurrence of intolerable toxicity.
Study NCT06362317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: When the body weight is ≥60 kg, the dosage of Lenvatinib is 12mg qd, when body weight \< 60kg the dosage is 8mg qd.
Study NCT06266390 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: The TMS intervention will involve two sets of Intermittent Theta-Burst Stimulation (iTBS) delivered every weekday for 4-6 weeks. Each iTBS set consists of 40 trains and a total of 1200 pulses, delivered approximately 15 minutes apart, resulting in 2400 pulses per session.
Study NCT05159076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention to Increase Physical Activity
Description: The educational program will consist of 2 classes held once a week, each lasting 90 minutes. The classes will be based on an education videotape, presentations and group discussions. The first class will address the asthma education. The second class will be about the current international physical activity recommendations and the importance and benefits of being physically active.~The behavioural intervention will be performed in 8 weekly goal-setting consultation, face-to-face, each lasting until 90 minutes. Patients will be offered a commercially-available activity tracker to wear during 3 days prior to each consultation. According to their own physical activity (PA) data and the behavioural change stage, an individual action plan will be established to increase physical activity. Each participant will receive individual counselling with the goal of increasing participation in PA and reducing their sedentary time.
Study NCT05825105 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma
Description: The PRP will be prepared using a single centrifugation process. Approximately 30 ml of peripheral blood will be drawn and collected into a vacutainer tubes with sodium citrate anticoagulant 0.129 mol/l (3.8%). The tubes will then be centrifuged at 900 RPM for 12 minutes at room temperature in a benchtop centrifuge. We will separate the lower third of the plasma fraction from all tubes with a syringe and needle, taking care to avoid the leukocyte layer. The PRP will be refrigerated at 4°C for no less than 1 hour. We will not use any exogenous factors to stimulate the platelet activation process. The periauricular skin surface will be disinfected with a povidone iodine solution, and an intra-articular local anesthetic with 1% lidocaine will be applied. A 21-gauge needle will be placed at the point of application. Finally, PRP will be injected into the joint, and the needle will be removed.
Study NCT06362317 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemox Chemotherapy（Gemox or GC）
Description: Chemotherapy drugs: GC regimen is preferred, and if patients cannot tolerate it, GEMOX regimen is used.~Gemcitabine + oxaliplatin (GEMOX) regimen chemotherapy: every 21 days (3 weeks), 1000 mg/m2 of gemcitabine was administered intravenously for more than 30 min on the 1st and 8th day, and 100 mg/m2 of oxaliplatin was administered intravenously for 2h on the 1st day Gemcitabine + cisplatin (GC) regimen chemotherapy: 1250 mg/m2 was administered intravenously for 30 min on day 1 and day 8, respectively, and 100 mg/m2 was administered intravenously for 2 hours after gemcitabine treatment on day 1.
Study NCT06362317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemox Chemotherapy（Gemox or GC）
Description: Chemotherapy drugs: GC regimen is preferred, and if patients cannot tolerate it, GEMOX regimen is used.~Gemcitabine + oxaliplatin (GEMOX) regimen chemotherapy: every 21 days (3 weeks), 1000 mg/m2 of gemcitabine was administered intravenously for more than 30 min on the 1st and 8th day, and 100 mg/m2 of oxaliplatin was administered intravenously for 2h on the 1st day Gemcitabine + cisplatin (GC) regimen chemotherapy: 1250 mg/m2 was administered intravenously for 30 min on day 1 and day 8, respectively, and 100 mg/m2 was administered intravenously for 2 hours after gemcitabine treatment on day 1.
Study NCT05263414 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tVNS
Description: tVNS allows the non-invasive activation of the Vagus Nerve by delivering electrical pulses to the sensory afferent fibers of the auricular, thick-myelinated, branch of the vagus nerve in the outer ear. TVNS seems to engage the same neural pathways of invasive VNS methods and may provide a novel, bottom-up NIBS method to promote GABA release. tVNS will be performed by using a CE marked tVNS device. It consists in a programmable stimulation unit connected to two titan ear electrodes that are mounted on a gel frame, allowing to generate and transfer electric impulses from the stimulation unit to the surface of the skin, where the electrodes are applied.
Study NCT05263414 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tVNS
Description: tVNS allows the non-invasive activation of the Vagus Nerve by delivering electrical pulses to the sensory afferent fibers of the auricular, thick-myelinated, branch of the vagus nerve in the outer ear. TVNS seems to engage the same neural pathways of invasive VNS methods and may provide a novel, bottom-up NIBS method to promote GABA release. tVNS will be performed by using a CE marked tVNS device. It consists in a programmable stimulation unit connected to two titan ear electrodes that are mounted on a gel frame, allowing to generate and transfer electric impulses from the stimulation unit to the surface of the skin, where the electrodes are applied.